rolling circle amplification
Rarity Bioscience Building Oncology Test Portfolio on Highly Sensitive 'SuperRCA' Technology
Premium
The Swedish company is scaling up the production of targeted mutation assay kits and plans to release some of them for research use by the end of the year.
Rarity Bioscience Closes $7M Funding Round
The Swedish molecular diagnostics startup will use the funds to advance its SuperRCA cell-free and genomic DNA detection technology.
Earlier this month, the company started accepting clinical samples at its CLIA/CAP laboratory in Pittsburgh and an affiliate laboratory in Malaysia.
The company plans to launch the system this summer in Europe, aiming to broaden cell-free DNA screening for trisomy 21, 18, and 13.
The company has been quietly working on a fully automated NIPT for trisomies 21, 13, and 18 that requires neither next-gen sequencing nor microarray technology.